Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer

Clinical Biochemistry
Man YuQinghua Zou

Abstract

To examine the association of BP1 mRNA level with tumor characteristics and clinical prognosis in non-small cell lung cancer (NSCLC) patients. Tumor specimens from 98 NSCLC patients who underwent surgical resection were quantitatively determined for BP1 mRNA expression by real-time RT-PCR. BP1 mRNA was expressed at significantly higher levels in tumors than in adjacent nontumorous tissues and normal lung samples. The level of BP1 transcript was significantly associated with tumor histological type and cell differentiation grade, but not related with other clinicopathological factors and p53 mutations. Patients with high BP1 mRNA expression had a poorer prognosis in terms of both disease-free survival (DFS) and overall survival (OS) rates. Additionally, BP1 mRNA expression level was an independent prognostic factor for DFS. BP1 may be part of a pathway contributing to NSCLC development and/or progression. BP1 mRNA level could be a novel prognostic marker for NSCLC.

References

Aug 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G FontaniniG Bevilacqua
Dec 5, 2000·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·T Zerucha, M Ekker
Jun 13, 2001·The European Respiratory Journal·J LaudanskiJ Niklinski
Jun 26, 2001·Journal of Cellular Physiology·C CilloE Boncinelli
Oct 3, 2002·Nature Reviews. Cancer·Cory Abate-Shen
Aug 2, 2003·Biology of the Neonate·Matthias Roth-Kleiner, Martin Post
Jan 24, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Christian GessnerHubert Wirtz
Nov 4, 2004·International Journal of Cancer. Journal International Du Cancer·Andreas StangKarl-Heinz Jöckel
Nov 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles LuFadlo R Khuri
Apr 15, 2005·Breast Cancer Research and Treatment·Yan-gao ManPatricia E Berg
Oct 4, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Shaija Samuel, Honami Naora
Apr 26, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Vincent C DanielD Neil Watkins
Jun 23, 2006·Medicinal Chemistry·K KuwanoY Nakanishi
Sep 28, 2006·Nucleic Acids Research·Marthe-Sandrine Eiymo Mwa MpolloMarie Trudel
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 10, 2007·International Journal of Cancer. Journal International Du Cancer·Yuan ChenIver Petersen
Aug 19, 2007·Chest·Wei ShiDavid Warburton
Sep 15, 2007·Breast Cancer Research : BCR·Holly S StevensonPatricia E Berg

❮ Previous
Next ❯

Citations

May 3, 2011·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Ryoichi KondoMakoto Kurai
Nov 19, 2011·Leukemia·I HommingaJ P P Meijerink
Oct 24, 2012·International Journal of Biological Sciences·Lianmei ZhangJunjiang Fu
Jan 13, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jing-Dong ZhouJun Qian
Jun 19, 2015·Biochemical and Biophysical Research Communications·Jing-Dong ZhouJun Qian
Apr 1, 2015·The Annals of Thoracic Surgery·Hiroaki HaradaMorihito Okada
Mar 27, 2018·Biomarkers in Medicine·Yaoxian LouPatricia E Berg
Nov 20, 2019·International Journal of Molecular Sciences·Fuyan HuXiaoping Liu
Oct 21, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Ting-Juan ZhangJun Qian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis